Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.36 |
| ▸ | TET3 | O43151 | 1/20 | 0.36 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.35 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.35 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.35 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL1561904 | 0.98 | TSHR (0.49) | TSHRTET2TET3TET1THRB | |
| Methacrylic Acid SCHEMBL4055237 | 0.88 | TSHR (0.45) | TSHRTHRBALDH1A1 | |
| SCHEMBL844666 | 0.85 | TSHR (0.49) | TSHRTHRBALDH1A1 | |
| SCHEMBL29927584 | 0.84 | TSHR (0.55) | TSHRTHRBALDH1A1TDP1 | |
| SCHEMBL7911797 | 0.84 | TSHR (0.47) | TSHRTHRBALDH1A1 | |
| SCHEMBL11864712 | 0.84 | THRB (0.41) | TSHRTET2TET3TET1THRB | |
| SCHEMBL35507 | 0.84 | TSHR (0.63) | TSHRTHRBALDH1A1POLBAPEX1 | |
| Methacrylic Acid SCHEMBL7599834 | 0.82 | TSHR (0.50) | TSHRTHRBALDH1A1POLBAPEX1 | |
| Methacrylic Acid SCHEMBL7607962 | 0.82 | TSHR (0.50) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL9336624 | 0.81 | TSHR (0.45) | TSHRTHRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117511169-B | Fireproof plastic and fireproof plastic flower | 惠州市启达环美科技有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117511169-A | Fireproof plastic and fireproof plastic flower | 惠州市启达环美科技有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-108366924-B | Cosmetic composition comprising a specific filler combination and a film-forming polymer to improve long-lasting effect | 莱雅公司 | 2021-03-02 | — | — | CN | claimed |
| EP-2945705-B1 | SOFT SOLID COSMETIC COMPOSITION COMPRISING ANIONIC SURFACTANTS AND SOLID PARTICLES, AND COSMETIC TREATMENT PROCESS | OREAL (FR) | 2021-02-24 | — | — | EP | claimed |
| EP-2945706-B1 | SOFT SOLID COSMETIC COMPOSITION COMPRISING ANIONIC SURFACTANTS AND POLYMERIC CONDITIONING AGENTS, AND COSMETIC TREATMENT METHOD | OREAL (FR) | 2021-01-06 | — | — | EP | claimed |
| US-20200390683-A1 | PORE HIDING COSMETIC COMPOSITION COMPRISING A PLATE TYPE FILLER, A SILICON ELASTOMER AND AN OIL ABSORBING FILLER | L'OREAL (FR) | 2020-12-17 | — | — | US | claimed |
| EP-2863995-B1 | PORE HIDING COSMETIC COMPOSITION COMPRISING A PLATE TYPE FILLER, A SILICON ELASTOMER AND AN OIL ABSORBING FILLER | OREAL (FR) | 2020-11-25 | — | — | EP | claimed |
| EP-3137045-B1 | COMPOSITION COMPRISING MICROCAPSULES CONTAINING PARTICLES WITH A HIGH WET POINT | OREAL (FR) | 2020-02-19 | — | — | EP | claimed |
| US-20190290557-A1 | EMULSION WITH MATTE EFFECTS AND EXCELLENT TEXTURE | L'OREAL (FR) | 2019-09-26 | — | — | US | claimed |
| CN-110236985-A | Extinction effect composition comprising hydrophobic aerogels and silica dioxide granule | 莱雅公司 | 2019-09-17 | — | — | CN | claimed |
| WO-2009071662-A2 | COSMETIC COMPOSITION HAVING IMPROVED PROPERTIES | L'OREAL (FR) | 2009-06-11 | — | — | WO | claimed |
| EP-1559393-B1 | Pressed powder cosmetic composition | OREAL (FR) | 2009-05-06 | — | — | EP | claimed |
| EP-1627624-B1 | Topical composition containing loaded porous particles and a sebum absorbing compound | OREAL (FR) | 2009-02-18 | — | — | EP | claimed |
| EP-1432428-B1 | Agent for colouring fibres containing keratin | HENKEL KGAA (DE) | 2006-11-02 | — | — | EP | claimed |
| US-20060039938-A1 | Cosmetic method of caring for greasy skin | L'OREAL (FR) | 2006-02-23 | — | — | US | claimed |
| US-20040265347-A1 | Cosmetic composition comprising a sebum-absorbing powder and a powder with a low critical surface energy | L'OREAL S.A. (FR) | 2004-12-30 | — | — | US | claimed |
| EP-0612241-A4 | IONIC BEADS USEFUL FOR CONTROLLED RELEASE AND ADSORPTION. | ADVANCED POLYMER SYSTEMS INC (US) | 1997-03-05 | — | — | EP | claimed |
| EP-0612241-A1 | IONIC BEADS USEFUL FOR CONTROLLED RELEASE AND ADSORPTION | Advanced Polymer Systems, Inc. (US) | 1994-08-31 | — | — | EP | claimed |
| US-5316774-A | Controlled release of drugs in intestines with enteric material and entrainment in polymers | ADVANCED POLYMER SYSTEMS, INC. (US) | 1994-05-31 | — | — | US | claimed |
| WO-1993007862-A1 | IONIC BEADS USEFUL FOR CONTROLLED RELEASE AND ADSORPTION | ADVANCED POLYMER SYSTEMS, INC. (US) | 1993-04-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190290557-A1 | EMULSION WITH MATTE EFFECTS AND EXCELLENT TEXTURE | APOB, FLOT1, VEGFA | TSHR 3223/4885TET2 1538/4885TET3 1442/4885 |
| US-20040265347-A1 | Cosmetic composition comprising a sebum-absorbing powder and a powder with a low critical surface energy | CUTA, MITF, SAMM50 | TSHR 1885/4885TET2 3289/4885TET3 3382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.